Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lore Santoro

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nuclear Medicine and Biology|December 18, 2021
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experienceJean-Pierre Pouget, Lore Santoro, Bérengère Piron, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 11, 2025
Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetryJosé-Alejandro Fragoso-Negrín, Lore Santoro, Kevin Hébert, et al.
Radiation Oncology (London, England)|September 20, 2007
Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancerAntoine Serre, Katia Idri, Pascal Fenoglietto, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic miceChristel Larbouret, Bruno Robert, Christine Linard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosisLore Santoro, Samir Boutaleb, Véronique Garambois, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Hepatobiliary Scintigraphy and Glass <sup>90</sup>Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated LiverCarole Allimant, Emmanuel Deshayes, Marilyne Kafrouni, et al.
Nutrients|July 14, 2023
Identification of <sup>18</sup>F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal CancerThierry Galvez, Ikrame Berkane, Simon Thézenas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC StudyEmmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nuclear Medicine and Biology|December 18, 2021
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experienceJean-Pierre Pouget, Lore Santoro, Bérengère Piron, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 11, 2025
Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetryJosé-Alejandro Fragoso-Negrín, Lore Santoro, Kevin Hébert, et al.
Radiation Oncology (London, England)|September 20, 2007
Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancerAntoine Serre, Katia Idri, Pascal Fenoglietto, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic miceChristel Larbouret, Bruno Robert, Christine Linard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosisLore Santoro, Samir Boutaleb, Véronique Garambois, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Hepatobiliary Scintigraphy and Glass <sup>90</sup>Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated LiverCarole Allimant, Emmanuel Deshayes, Marilyne Kafrouni, et al.
Nutrients|July 14, 2023
Identification of <sup>18</sup>F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal CancerThierry Galvez, Ikrame Berkane, Simon Thézenas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC StudyEmmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Pageof 3